Wall Street is positive on Guardant Health Inc (GH). On average, analysts give GH a Strong Buy rating. The average price target is $121.5, which means analysts expect the stock to rise by 272.01% over the next twelve months. That average ranking earns GH an Analyst Rating of 68, which is better than 68% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating GH a Strong Buy today. Find out what this means to you and get the rest of the rankings on GH!